A global survey of potential acceptance of a COVID-19 vaccine

Type Journal Article Author Jeffrey V. Lazarus Author Scott C. Ratzan Author Adam Palayew Author Lawrence O. Gostin Author Heidi J. Larson Author Kenneth Rabin Author Spencer Kimball Author Ayman El-Mohandes URL https://www.nature.com/articles/s41591-020-1124-9 Rights 2020 The Author(s), under exclusive licence to Springer Nature America, Inc. Series Brief communication Pages 1-4 Publication Nature Medicine ISSN 1546-170X Date 20/10/2020 Extra Publisher: Nature Publishing Group DOI 10.1038/s41591-020-1124-9 Library Catalog www.nature.com Language en Abstract Several coronavirus disease 2019 (COVID-19) vaccines are currently in human trials. In June 2020, we surveyed 13,426 people in 19 countries to determine potential acceptance rates and factors influencing acceptance of a COVID-19 vaccine. Of these, 71.5% of participants reported that they would be very or somewhat likely to take a COVID-19 vaccine, and 61.4% reported that they would accept their employer’s recommendation to do so. Differences in acceptance rates ranged from almost 90% (in China) to less than 55% (in Russia). Respondents reporting higher levels of trust in information from government sources were more likely to accept a vaccine and take their employer’s advice to do so.